Document is current
Any future updates will be listed below
-
Authors
Liu, Zhongle
Yiu, Bonnie
Basso, Pauline
Chen, Xuefei https://orcid.org/0009-0006-6304-5777
Patel, Disha https://orcid.org/0009-0005-5132-6451
Davie, Taylor
Hossain, Saif
Fu, Ci
Archambault, Linda S.
Duncan, Dustin https://orcid.org/0000-0003-1240-8495
Wright, Gerard D. https://orcid.org/0000-0002-9129-7131
Noble, Suzanne M.
Robbins, Nicole https://orcid.org/0000-0003-2821-9269
Cowen, Leah E. https://orcid.org/0000-0001-5797-0110
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (1R01AI127375)
- License Information
-
More Information
Article History
Received: 21 June 2025
Accepted: 6 November 2025
First Online: 12 December 2025
Competing interests
: L.E.C. is a co-founder and shareholder in Bright Angel Therapeutics, a platform company for the development of novel antifungal therapeutics. L.E.C. is a Science Advisor for Kapoose Creek, a company that harnesses the therapeutic potential of fungi. All other authors declare no competing interests.
